Whole-brain N-acetylaspartate level and cognitive performance in HIV infection

American Journal of Neuroradiology

Volumn 24, Issue 8, 2003, Pages 1587-1591

  Patel, Sohil H ^a   Inglese, Matilde ^a   Glosser, Guila ^b   Kolson, Dennis L ^b   Grossman, Robert I ^a   Gonen, Oded ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; AIDS RELATED COMPLEX; ARTICLE; BRAIN ATROPHY; BRAIN FUNCTION; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE QUALITY; MALE; MEMORY; MOOD; MOTOR PERFORMANCE; NERVE CELL; NERVE FIBER; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; SCORING SYSTEM;

ADULT; AIDS DEMENTIA COMPLEX; ASPARTIC ACID; ATROPHY; BRAIN; DISEASE PROGRESSION; ENERGY METABOLISM; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEURONS; NEUROPSYCHOLOGICAL TESTS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0141855284     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. McArthur JC, Sacktor N, Selnes O. Human immunodeficiency virus-associated dementia. Semin Neurol 1999;19:129-150
2. Navia BA, Dafni U, Simpson D, et al. A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology 1998;51:221-228
3. Bencherif B, Rottenberg DA. Neuroimaging of the AIDS dementia complex. Aids 1998;12:233-244
4. Power C, Kong PA, Crawford TO, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993;34:339-350
5. Gray F, Scaravilli F, Everall I, et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996;6:1-15
6. Pomara N, Crandall DT, Choi SJ, Johnson G, Lim KO. White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res 2001;106:15-24
7. Filippi CG, Ulug AM, Ryan E, Ferrando SJ, van Gorp W. Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain AJNR Am J Neuroradiol 2001;22:277-283
8. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45:37-45
9. Lopez-Villegas D, Lenkinski RE, Frank I. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 1997;94:9854-9859
10. Moller HE, Vermathen P, Lentschig MG, et al. Metabolic characterization of AIDS dementia complex by spectroscopic imaging. J Magn Reson Imaging 1999;9:10-18
11. Wilkinson ID, Miller RF, Miszkiel KA, et al. Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection. Aids 1997;11:289-295
12. Meyerhoff DJ, MacKay S, Bachman L, et al. Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo IH magnetic resonance spectroscopic imaging. Neurology 1993;43:509-515
13. Chong WK, Sweeney B, Wilkinson ID, et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 1993;188:119-124
14. Laubenberger J, Haussinger D, Bayer S, et al. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 1996;199:805-810
15. Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I. Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 1993;186:739-744
16. McConnell JR, Swindells S, Ong CS, et al. Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. AIDS Res Hum Retrovir 1994;10:977-982
17. Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 1999;52:100-108
18. Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 1999;52:995-1003
19. Ernst T, Itti E, Itti L, Chang L. Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: a coregistered (1)H MRS and SPECT study. J Magn Reson Imaging 2000;12:859-865
20. Patel SH, Kolson DL, Glosser G, et al. Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients. AJNR Am J Neuroradiol 2002;23:543-549
21. Gonen O, Viswanathan AK, Catalaa I, Babb J, Udupa J, Grossman RI. Total brain N-acetylaspartate concentration in normal, age-grouped females: quantitation with non-echo proton NMR spectroscopy. Magn Reson Med 1998;40:684-689
22. Dana T. Consortium on Therapy for HIV Dementia and Related Cognitive Disorders: a randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment-Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. Neurology 1998;50:645-651
23. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder - The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology 1996;47:1247-1253
24. Gonen O, Grossman RI. The accuracy of whole brain N-acetylaspartate quantification. Magn Reson Imaging 2000;18:1255-1258